JPRN-jRCTs051200049进行中(未招募)2 期
Multicenter Study to evaluate efficacy and safety of Demethylchlortetracycline in Patients of COVID-19 - COVID-DMC
Iwahori Kota0 个研究点目标入组 42 人开始时间: 2020年8月26日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 < 75age old(—)
- 性别
- All
入选标准
- •1) Patients who are positive for SARS-CoV-2 by PCR or antigen test
- •2) Patients who do not need continuous (24h) oxygen inhalation
- •3) Patients who can eat and drink
- •4) Patients older or equal to 20 years old and younger than 75 years old
- •5) Patients who can sign the informed consent form by themselves
排除标准
- •1) Patients with hypersensitivity for tetracycline compound
- •2) Patients showing SpO2 < 93% without oxygen inhalation
- •3) Patients who are or have a possibility to be pregnant, or hope to be pregnant during the study.
- •4) Patients with liver failure (AST and/or ALT >= the standard value)
- •5) Patients with kidney failure (eGFR < 30 ml/min/1.73m2)
- •6) Patients who had a COVID-19 vaccination
- •7) Patients who are considered unsuitable for the study by the PI or sub investigators
研究者
相似试验
已完成
不适用
Multicenter study to evaluate efficacy and safety of FINESIA system in dental implant treatment.Single tooth gaps in premolar region, first molar and second molar.JPRN-UMIN000025819Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University40
已完成
2 期
A multicentre study to assess safety and efficacy of COMP360 in patients with treatment-resistant depression following completion of COMP 001 and COMP 003 trials (P-TRD LTFU)treatment resistant depression10027946NL-OMON55052COMPASS Pathfinder Ltd3
进行中(未招募)
1 期
ong Term Follow up study for subjects that participated in COMP001 and COMP003 trialTreatment-Resistant Depression (P-TRD)MedDRA version: 21.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873EUCTR2020-001348-25-CZCOMPASS Pathfinder, Ltd150
进行中(未招募)
1 期
ong Term Follow up study for subjects that participated in COMP001 and COMP003 trialEUCTR2020-001348-25-PTCOMPASS Pathways, Ltd150
进行中(未招募)
1 期
ong Term Follow up study for subjects that participated in COMP001 and COMP003 trialTreatment-Resistant Depression (P-TRD)MedDRA version: 21.1Level: LLTClassification code 10025463Term: Major depressive disorder, single episodeSystem Organ Class: 100000004873MedDRA version: 21.1Level: LLTClassification code 10025454Term: Major depressive disorder, recurrent episodeSystem Organ Class: 100000004873EUCTR2020-001348-25-NLCOMPASS Pathfinder, Ltd150
